GGrantIndex
Sort

23,748 grants matching melanoma

Reducing Errors in the Diagnosis of Melanoma and Melanocytic Lesions

$676,449
Joann G Elmore · University Of Washington · R01 · FY2016 · CA

Likes Pins and Views: Engaging Moms on Teen Indoor Tanning Thru Social Media

$676,417
David B Buller · Klein Buendel, Inc. · R01 · FY2015 · CA

Overcoming adaptive feedback resistance to KRAS inhibition in colorectal cancer

$676,391
Ryan Bruce Corcoran · Massachusetts General Hospital · R01 · FY2024 · CA

Development of Physiologic Tissue Models to Assess Tumor Explant Response to Immune Checkpoint Blockade

$676,329
Roger D. Kamm · Massachusetts Institute Of Technology · U01 · FY2020 · CA

CHARACTERIZATION OF NEUROPILIN, A NOVEL VEGF RECEPTOR

$676,241
Michael Klagsbrun · Boston Children'S Hospital · R37 · FY2007 · CA

Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium

$676,113
Theresa A Freeman · Thomas Jefferson University · R01 · FY2022 · AR

Mechanisms that couple irregular development of fetal melanoblasts to premature exhaustion of adult melanocyte stem cells

$676,107
Peter D. Adams · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · AR

Development of Aquatic Model Resources for Therapeutic Screens

$675,794
John Harvey Postlethwait · University Of Oregon · R24 · FY2014 · OD

Focused Ultrasound Regimens that Synergize with Melanoma Immunotherapy

$675,709
Richard J Price · University Of Virginia · R01 · FY2020 · EB

Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion

$675,590
Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways

$675,590
Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Clinical Pregnancy Outcomes in Adolescent and Young Adult Female Cancer Survivors

$675,579
Hazel B Nichols · Univ Of North Carolina Chapel Hill · R01 · FY2017 · CA

Skin Disease Research Center

$675,487
Thomas S. Kupper · Brigham And Women'S Hospital · P30 · FY2007 · AR

Skin Disease Research Center

$675,487
Thomas S. Kupper · Brigham And Women'S Hospital · P30 · FY2008 · AR

(PQ3) Cellular and Molecular Mechanisms Driving Myeloid Compartment Variation in Human Triple Negative Breast Cancer

$675,289
Anna Karolina Palucka · Jackson Laboratory · R01 · FY2021 · CA

Identifying modifiable factors that reduce the burden of late stage melanoma in Hispanics

$675,213
Myles G Cockburn · University Of Southern California · R01 · FY2021 · CA

A hybrid effectiveness-implementation trial to integrate precision skin cancer risk feedback in federally qualified health centers

$675,011
Peter A Kanetsky · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA

Rewiring T cell exhaustion with immune checkpoint blockade therapy

$674,996
Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · CA

Rewiring T cell exhaustion with immune checkpoint blockade therapy

$674,996
Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · CA

The Role of TIMPs in Cell Growth and Differentiation: Tumor Angiogenesis

$674,959
William Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA

Immunogenetic determinants of cancer risk

$674,787
Robert M Samstein · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA

Development of Non-Catalytic Peptide Inhibitors of Focal Adhesion Kinase (FAK) for Use in Melanoma

$674,537
Timothy A Marlowe · Faknostics, Llc · R42 · FY2021 · CA

Adoptive Transfer of MART-1 TCR Engineered Cells after a Myelodepleting Regimen

$674,507
Antoni Ribas · California Institute Of Technology · P01 · FY2012 · CA

Multiscale Modeling to Optimize Inhibition of Oncogenic ERK Pathway Signaling

$674,422
Mark A. Lemmon · Yale University · R01 · FY2022 · CA

Enhancing cell therapy for brain tumors

$674,256
Catherine Mary Bollard · Children'S Research Institute · U01 · FY2018 · CA